| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
B Activity Underlies the Pro- and Anti-Inflammatory Actions of Nitric Oxide1
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
B, which regulates the expression of many
host defense proteins. In the present study, we characterize a novel,
biphasic effect of NO on NF-B activity in murine macrophages. This
mechanism depends on the local concentration of NO and enables it both
to up- and down-regulate the expression of host defense proteins
including iNOS, cyclooxygenase-2, and IL-6. This biphasic activity of
NO appears to play a pivotal role in the time course of activation of
these immune cells and, by inference, in facilitating the initiation of
a defense response against pathogenic stimuli and in its termination to
limit tissue damage. This mechanism may explain at least in part the
reported ability of NO to act in both a pro- and anti-inflammatory
manner. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
, IL-2, IFN-
, TNF-
, and
bacterial metabolites such as LPS (4, 5, 6). The inherent
activity exhibited by iNOS results in the production of high output NO,
which is cytotoxic and cytostatic to a number of pathogens and tumor
cells; this is mediated via inhibition of various enzymes within target
cells, including complexes I and IV of the mitochondrial respiratory
chain (7, 8, 9), ribonucleotide reductase (10),
aconitase (3), and GAPDH (11), and through
DNA modification (12, 13).
In murine macrophages, regulation of iNOS expression is governed
predominantly by the transcription factor NF-B, which is expressed
ubiquitously and is essential for the inducible expression of genes
associated with immune and inflammatory responses (e.g., cytokines,
adhesion molecules, antioxidant enzymes) (for review, see Refs.
14 and 15). NF-B belongs to the larger
NF-B/Rel family of transcription factors that exist as homo- or
heterodimers in the cytosol of most mammalian cells, sequestered in a
quiescent state via interaction with a class of inhibitory proteins,
termed IBs. NF-B can be activated by a number of immunological
and pathological stimuli, including cytokines, oxidative stress, UV
light, and bacterial and viral products. Following the appropriate
stimuli, activation of an IB kinase occurs, which results in
phosphorylation of the IB followed by polyubiquitination. These
modifications result in rapid proteolysis of the IB by the 26S
proteosome, thereby releasing the active NF-B complex, which
translocates to the nucleus and binds the DNA at a specific consensus
sequence (5'-GGGRNNYYCC-3') to promote transcription of target genes.
NF-B consensus sites have been found in the promoter sequence of
many proinflammatory proteins, including human and murine iNOS
(6); accordingly, agents that modulate the activity of
NF-B have a pronounced effect on iNOS expression in response to
different inflammatory stimuli (16, 17, 18, 19).
It is now becoming clear that NO plays a pivotal role in the regulation
of gene expression. One key facet of this regulatory activity may be
the control of iNOS induction. Such a mechanism would constitute a
self-regulating pathway by which NO production from this NOS isoform
could be fine-tuned, which is essential since iNOS is regulated
transcriptionally rather than biochemically. Previous reports have
suggested that NO has an inhibitory effect on iNOS expression
(20, 21, 22, 23) and that this effect may be mediated at least in
part by decreased NF-B activity (22, 24, 25, 26, 27, 28). The
mechanisms underlying this phenomenon are not clear, but may involve
stabilization of the inhibitor protein IB (29) or
nitrosation of the p50 subunit of NF-B (which decreases its
DNA-binding affinity) (30, 31, 32). In contrast, under certain
conditions NO has been reported to augment the expression of host
defense proteins, including cyclooxygenase-2 (COX-2)
(33, 34, 35), TNF- (36), and
glutathione-synthesizing enzymes (37), possibly by
potentiating NF-B activity (38). Moreover, iNOS
expression can be both up- and down-regulated in murine (ANA-1)
macrophages by NO (39). Such observations hint that the
action of NO in regulating gene expression is likely to be multifaceted
and may involve both positive and negative effects. Moreover, the
majority of the above observations have been made using exogenous NO
sources, and the role of endogenous NO on NF-B activity and
proinflammatory protein expression remains to be elucidated.
In the present study, we demonstrate that NO has a patent biphasic
effect on NF-B activity in murine macrophages and hence possesses
the ability to both up- and down-regulate the expression of a number of
proinflammatory proteins, including iNOS, COX-2, and IL-6. The dual
effects of NO on NF-B has a pronounced effect on the activation
profile of immune cells and therefore has important implications for
both the initiation and the suppression of an immune/inflammatory
response. The dual effects of NO on NF-B may also explain in part
the ability of NO to exert both pro- and anti-inflammatory actions
(40).
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Salmonella typhosa (serotype 0901) LPS was purchased from Difco (Detroit, MI). Diethylamine-NONOate (DEA-NO) was obtained from Cayman Chemicals (supplied by Alexis, Nottingham, U.K.). All other chemicals were purchased from Sigma (Poole, U.K.).
Cell culture
Murine macrophages (RAW 264.7 cells) were purchased from American Type Culture Collection (TIB 71; Manassas, VA). Cells were cultured in suspension in a glass stirrer bottle in RPMI 1640 (with 25 mM HEPES) supplemented with 10% heat-inactivated New Zealand FCS (low endotoxin), 2 mM glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin (Life Technologies, Paisley, U.K.; complete medium). The cell cultures were maintained as a stirred culture at 37°C in a humidified incubator containing 5% CO2 in air.
In L-arginine-free experiments, medium was prepared using RPMI 1640 (with 25 mM HEPES) free from L-arginine (Life Technologies) supplemented with 10% dialyzed, heat-inactivated New Zealand FCS (low endotoxin), and glutamine, penicillin, and streptomycin as described above (L-arginine-free medium).
RAW 264.7 macrophages were incubated for 24 h (as above) in 75-cm2 flasks at a concentration of 5 x 106 cells/flask in 10 ml of complete medium (unless otherwise stated). Before activation with LPS (1 µg/ml), the medium was removed, and the cells were washed with 5 ml of PBS and replenished with complete medium or L-arginine-free medium. In certain experiments, cells were preincubated for 15 min with NG-nitro-L-arginine methyl ester (L-NAME; 1 mM) before activation with LPS. Flasks were then incubated as described above. At appropriate time points, medium was removed from flasks, and an aliquot was stored at -20°C for IL-6 and nitrite measurement. The remaining medium was discarded, cells were washed with 5 ml of PBS, and following addition of 1.5 ml of Accutase (TCS, Botolph Claydon, U.K.) flasks were incubated for an additional 10 min. Cells were dislodged and washed three times by centrifugation (200 x g, 5 min, 4°C) with PBS, and pellets were stored at -80°C.
Western blot analysis
Cell pellets were homogenized in 50 mM Tris-HCl (pH 7.5), 0.1 mM DTT, 0.2 mM EDTA, and 10 µg/ml protease inhibitor cocktail (benzamidine, leupeptin, aprotinin, and antipain) by sonication. The resulting lysate was centrifuged (105,000 x g, 30 min, 4°C), and the supernatant was retained. Protein concentrations were determined by protein assay (Bio-Rad, Hemel Hempstead, U.K.). Equal volumes of protein were subjected to 7.5% SDS-PAGE under reducing conditions. The proteins were transferred to nitrocellulose membranes (Pharmacia, Amersham, U.K.) with a semidry blotter (Pharmacia) at 120 mA for 60–90 min. The membranes were then incubated with shaking in 5% milk in wash buffer (PBS/0.1% Tween 20) for 1 h at room temperature. The membrane was washed twice (15 min/wash) in wash buffer before incubation overnight at 4°C with gentle shaking, with primary Ab (anti-iNOS (Transduction Laboratories, Lexington, KY), anti-COX-2 (Cayman Chemicals, Ann Arbor, MI), and anti-actin (Chemicon, Temesula, CA) diluted 1/2000 (anti-iNOS), 1/3000 (anti-COX-2), or 1/500 (anti-actin)) in 1% milk in wash buffer. The membrane was washed six times (5 min/wash) and then incubated, with gentle shaking for 2 h at room temperature, with HRP-conjugated anti-rabbit IgG (Vector Laboratories, Burlingame, CA) diluted 1/5000 in 1% milk in wash buffer. The membrane was washed as previously, and proteins were visualized using enhanced chemiluminescence (Amersham, Aylesbury, U.K.). Bands were quantified by densitometry (NIH Image).
RNA isolation and RT-PCR
RNA was extracted from cells using a simple nucleic acid preparation Total RNA Isolation kit (Invitrogen, Groningen, The Netherlands). Random hexamers (0.15 ng/reaction; Life Technologies) were added to equal amounts of RNA made up to a 12-µl volume in diethylpyrocarbonate-treated water. The mixture was heated at 70°C for 10 min, then cooled immediately on ice. DTT (10 mM), first-strand buffer (supplied with enzyme), and PCR nucleotide mix (0.5 mM; Roche Molecular Biochemicals, Lewes, U.K.) were added to a final volume of 20 µl, and the mix was heated at 25°C for 10 min. RT was then conducted at 42°C for 55 min, with 200 U of Superscript II RNase H reverse transcriptase (Life Technologies) added after 2 min of incubation. The mixture was then heated at 70°C for 15 min and stored at -20°C.
PCR was performed on a Primus 96 Thermocycler (MWG Biotech, Milton Keynes, U.K.) in a reaction containing 0.2 mM PCR nucleotide mix (Roche Molecular Biochemicals), forward and reverse primers (1 µM each), 1x PCR buffer with MgCl2 (supplied with enzyme), 1 µl of cDNA, and 1 U of Taq DNA polymerase (Roche Molecular Biochemicals) made up to 25 µl with distilled water. The same master mix containing all reagents was used for each sample. Thermal cycling conditions were as follows: 95°C for 5 min, then 22 cycles of denaturation at 95°C for 1 min, annealing at 58°C for 2 min, and polymerization at 72°C for 2 min, followed by a final extension at 72°C for 10 min. PCR products were resolved by agarose gel electrophoresis (2% gel) and stained with ethidium bromide. Preliminary experiments were performed to ensure that the number of cycles used gave a product quantity that was on the linear portion of the PCR amplification curve (data not shown).
Primer sequences (Genosys, Cambridge, U.K.) were: iNOS sense, 5'-GCATTTGGGAATGGAGACTG-3'; iNOS antisense, 5'-GTTGCATTGGAAGTGAAGCGTTTC-3'; COX-2 sense, 5'-GAGGTACCGCAAACGCTT-3'; COX-2 antisense, 5'-TTATTGCAGATGAGAGACTG-3'; GAPDH sense, 5'-ATGGTGAAGGTCGGTGTGAACG-3'; and GAPDH antisense, 5'-GGCGGAGATGATGACCCGTTTGGC-3'.
EMSA
Cells (7 x 106) were seeded in
complete medium in 10-cm tissue culture dishes, then incubated and
activated as described above. Nuclear extracts were prepared by washing
the adhered cells with cold PBS and adding cold buffer A (10 mM HEPES
(pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT,
and 0.2% Nonidet P-40). The dish was scraped, and the reaction volume
was centrifuged (1850 x g, 1 min, 4°C). Supernatants
were discarded, and the nuclear pellets were resuspended in 60 µl of
buffer C (20 mM HEPES (pH 7.9), 25% glycerol, 0.42 M NaCl, 1.5 mM
MgCl2, 0.5 mM DTT, and 0.2 mM EDTA) and left on
ice for 30 min. A protease inhibitor cocktail tablet (Roche) was added
to buffers A and C. The solution was centrifuged (1850 x
g, 2 min, 4°C), and the supernatants were recovered as
nuclear extracts. The protein concentration was measured by the Bio-Rad
protein assay. Samples were aliquoted and stored at -20°C. A
double-stranded oligonucleotide containing an NF-B consensus
sequence (5'-GGGGACTTTCC-3'; Promega) was end labeled using
[-32P]ATP and T4 polynucleotide kinase
(Promega). Probes were purified using Centri-sep spin columns
(Princeton Separations, Sigma, Genosys, Cambridge, U.K.). For each
experiment protein DNA-binding reactions were performed using equal
amounts of nuclear extract protein (2–3 µg) and labeled
oligonucleotide in the presence of incubation buffer (1 mM
MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl, 10 mM
Tris-HCl (pH 7.5), 0.05 µg/µl poly(dI-dC), and 4% glycerol) for 30
min on ice. To ensure specificity of probe binding, certain experiments
were conducted in the presence of a 100-fold molar excess of unlabeled
(cold) NF-B consensus oligonucleotide (data not shown.). Protein-DNA
complexes were resolved in 5% polyacrylamide gels, electrophoresed for
1 h at room temperature in 0.5x TBE (45 mM Tris-borate and 1 mM
EDTA, pH 8.0). Gels were exposed to x-ray film overnight at -80°C.
Bands were quantified by densitometry (NIH Image).
IL-6 and nitrite measurement
IL-6 was measured using the Quantikine M mouse IL-6 quantitative colorimetric sandwich ELISA from R&D Systems (Abingdon, U.K.) according to the manufacturer’s instructions. Nitrite accumulation was determined by mixing equal volumes of cell culture medium and Griess reagent (0.5% sulfanilamide, 0.05% naphthylethylenediamine dihydrochloride, and 2.5% H3PO4) with absorbance (A540–A620) read on a Molecular Devices 96-well microplate reader (Menlo Park, CA); standard curves were constructed with known concentrations of NaNO2.
Data analysis
All statistical analyses were performed using GraphPad Prism (GraphPad Software, San Diego, CA). Densitometric analyses were performed using NIH Image. All data are plotted graphically as mean values, with vertical bars representing SEMs. Student’s t test was used to assess differences between experimental conditions. A p < 0.05 was taken as an appropriate level of significance.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Activation of RAW 264.7 cells with LPS (1 µg/ml) produced a
time-dependent expression of iNOS and COX-2 mRNA and protein. In both
cases, protein expression peaked between 12 and 24 h and had
decreased by 75% of maximum by 48 h (Figs. 1
and 2).
mRNA expression for both proteins followed a very similar pattern but
peaked between 9 and 12 h (data not shown). In cells cultured in
L-arginine (substrate)-free medium, the time course of iNOS
and COX-2 protein expression was significantly altered, such that peak
expression was delayed until 48 h, and substantial levels of
protein were still present at 96 h (Figs. 1 and 2). mRNA
expression was delayed in a similar manner, peaking at 24–48 h (data
not shown). This protracted rise and fall in protein expression was
also observed in the presence of the NOS inhibitor L-NAME
(Figs. 1 and 2). However, the effect of L-NAME was not as
marked as that seen with cells cultured in L-arginine-free
medium. Peak iNOS and COX-2 protein expression in response to LPS was
reduced significantly in cells in which endogenous NO production was
inhibited; in cells cultured in L-arginine-free medium,
iNOS and COX-2 proteins levels reached 75.4 ± 7.8%
(n 
3; p < 0.05) and 80.4 ±
12.6% (n 3; p < 0.05) of control
values, respectively.
|
|
35 µM nitrite over a 96-h period. Cells cultured in
L-arginine-free medium did not produce any significant
concentrations of nitrite over the same time period (Fig. 3). However, in the presence of
L-NAME (1 mM), nitrite accumulation was significantly
inhibited, but still reached a peak of about 15 µM (45% of
control; Fig. 3). L-NAME itself did not cause any nitrite
accumulation in the absence of LPS (data not shown).
|
To verify the effect of inhibition of endogenous NO synthesis on
the cellular response to LPS, the production of a third inflammatory
mediator, IL-6, was assessed. Accumulation of IL-6 in the supernatant
following activation of murine macrophages with LPS peaked at 72–96 h,
after which time no further production was observed. In the presence of
L-NAME (1 mM) or in cells cultured in
L-arginine-free medium, production of IL-6 was
significantly retarded at time points up to 12 h, but exceeded
levels seen in controls at later time points (Fig. 4). As was observed with the expression
of iNOS and COX-2 protein, the effect of L-NAME on IL-6
production was reduced compared with that in
L-arginine-free medium. However, a similar pattern of
activity of endogenous NO on IL-6 production as that seen with iNOS and
COX-2 mRNA and protein was revealed.
|
To study the differential activity of NO in the early (9 h) and
late (24 h) phases of macrophage activation, endogenous NO synthesis
was inhibited at different times following LPS stimulation. In the
first series of experiments, L-NAME (1 mM) was present
throughout; in this case, expression of iNOS protein 9 h after
activation with LPS was significantly reduced compared with the control
value (Fig. 5A). In contrast,
if inhibition of endogenous NO synthesis was established with
L-NAME (1 mM) at 9 h subsequent to LPS
activation, expression of iNOS protein at 24 h was markedly higher
in treated cells (Fig. 5A).
|
B activity
To examine whether the effect of inhibition of endogenous NO
synthesis on iNOS and COX-2 mRNA/protein expression and IL-6 production
might be the result of a modification of the transcription factor
NF-B, EMSAs were conducted. Under control conditions, activation of
RAW 264.7 cells with LPS resulted in a time-dependent increase in
NF-B activity, which peaked between 1–2 h and approached baseline
values after 24 h (data not shown). Studies were conducted to
examine the effect of inhibition of endogenous NO synthesis at
different time points following cellular activation with LPS. Addition
of L-NAME (1 mM) to cells 15 min before LPS resulted in a
significant decrease in NF-B activity as measured at 90 min (Fig. 5
B). In contrast, addition of L-NAME
(1 mM) 9 h subsequent to LPS elicited a marked increase in NF-B
activity as assessed at 24 h (Fig. 5B).
Effect of exogenous NO on NF-B activity
To investigate more extensively the effect of NO on NF-B
activity in murine macrophages, the NO donor DEA-NO was used as an
exogenous source of NO. DEA-NO releases NO spontaneously in aqueous
solution with a half-life of 3 min at 37°C (41).
Addition of DEA-NO at increasing concentrations (30 nM to 300 µM) to
the RAW 264.7 cells immediately before addition of LPS caused a
distinct biphasic effect on NF-B activity as assessed by EMSA 90 min
subsequent to activation (Fig. 6). At
lower concentrations (30 nM to 3 µM) DEA-NO caused a significant
enhancement of NF-B activity, whereas at higher concentrations (30
µM to 300 µM) DEA-NO produced an inhibition of NF-B activity
(Fig. 6). The peak NO levels attained from this range of DEA-NO
concentrations are given in Table I; such
figures correspond closely with those reported previously
(42).
|
|
To investigate whether the biphasic effect of NO on NF-B
activity was reflected by an analogous change in the expression of
proteins regulated by this transcription factor, the effect of DEA-NO
on iNOS and COX-2 mRNA and protein expression was studied 24 h
after activation. Mirroring the effects observed with NF-B, both
iNOS and COX-2 mRNA and protein expression were affected in a biphasic
manner by DEA-NO (30 nM to 300 µM) given concomitantly with LPS. As
before, lower concentrations of DEA-NO (30 nM to 3 µM) caused a
potentiation of mRNA and protein expression, whereas higher
concentrations (30 µM to 300 µM) elicited an inhibitory effect
(Fig. 7). DEA-NO (30 nM to 300 µM)
alone was unable to induce iNOS protein expression (data not
shown).
|
Cell viability, as measured by trypan blue exclusion, was not altered significantly by any of the experimental conditions (data not shown).
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
B. Via this
mechanism, which depends on its local concentration, NO is able both to
turn on and turn off the expression of a diverse range of proteins
regulated by this transcription factor and to modulate the activation
profile of immune cells. In murine macrophages stimulated with LPS,
expression of iNOS and COX-2 follows a distinctive pattern,
characterized by a rapid onset that peaks at 12 h followed by a
swift cessation of protein expression (43, 44). This study
shows that when macrophages are activated in
L-arginine-free medium, which is known to lead to the
complete suppression of endogenous NO synthesis (45), the
time course of activation changes considerably, with the peak response
being significantly delayed and expression of inducible proteins
maintained for prolonged periods. Interestingly, incubation of cells in
normal medium, but in the presence of L-NAME to inhibit
endogenous generation of NO, leads to a similar, but less pronounced,
change in the profile of activation; this can be explained by the fact
that complete suppression of nitrite accumulation (and hence NO
production) was not achieved under these conditions. Nevertheless, this
correlation between nitrite accumulation and modulation of iNOS/COX-2
expression provides further evidence that the activation profile of the
macrophages is closely linked to NO production. Moreover, peak protein
expression in cells cultured in L-arginine-free medium or
exposed to L-NAME was reduced compared with the control
value. This suggests that if the initial NO-mediated facilitation of
the response to LPS is not present, then the magnitude of the
activation is diminished. To investigate this phenomenon further, experiments were conducted in which cells were activated in the presence of L-NAME, or this intervention was established 9 h after activation. The results from these studies substantiated the initial observations, since the presence of L-NAME at the early stages of activation decreased iNOS expression, whereas the same conditions established at 9 h potentiated iNOS expression. Thus, at earlier time points NO augments activation, producing a sharp rise and peak in protein expression, while at later time points, NO has an inhibitory effect on the cells, such that a rapid termination of activation is brought about.
The present study is therefore in agreement with reports that ascribe
to NO a regulatory role on gene expression and may explain in part why
NO has been reported both to inhibit the expression of proinflammatory
proteins (e.g., iNOS (23, 39), COX-2 (28),
cytokines (24, 46, 47, 48, 49), adhesion molecules (25, 50), MHC class II molecules (51), and thioredoxin
(52) and enhance their expression (e.g., iNOS
(39), COX-2 (33, 34, 35), TNF-
(36), and glutathione-synthesizing enzymes
(37)). This study also demonstrates clearly that
regulation of gene expression by NO is inherently versatile,
encompassing both up- and down-regulation.
Since NF-B is known to be involved in iNOS expression in murine and
human macrophages, EMSAs were used to demonstrate that the effects of
NO observed in the present study were exerted via an action on NF-B.
Inhibition of endogenous NO production elicited a marked inhibitory
effect on NF-B activity measured 90 min after exposure to LPS.
However, following inhibition of endogenous NO synthesis 9 h
subsequent to activation, NF-B activity at 24 h was markedly
enhanced. This pattern of activity mirrors that observed with iNOS
protein expression, implying that the effects of NO are mediated via
modulation of NF-B activity. To explore this possibility further,
the effect of exogenous NO on NF-B activity was investigated. The
biphasic nature of NO-mediated modulation of NF-B activity was
clearly evident under these conditions. The NO donor DEA-NO produced a
concentration-dependent influence on NF-B, which comprised
enhancement at concentrations between 30 nM and 3 µM followed by
inhibition at concentrations of 30–300 µM. The peak levels of NO
produced by these concentrations of DEA-NO range from 1 nM to 2 µM,
which correspond approximately to levels of NO produced by constitutive
NOS under physiological conditions and iNOS under pathological
conditions, respectively. Thus, both constitutive and inducible NOS
isoforms might be involved in the up- and down-regulation of NF-B
activity and gene expression in vivo. Certainly, the effects of DEA-NO
could not be attributed to toxicity, since cell viability was not
significantly changed by any of the concentrations used. To ensure that
these actions of NO on NF-B activity were reflected by similar
differences in mRNA and protein expression, we looked at both these
parameters for iNOS and COX-2. Indeed, in both cases the expression of
mRNA and protein in the presence of increasing concentrations of DEA-NO
mirrored the biphasic pattern observed with NF-B, suggesting that
the NO-mediated alteration in NF-B activity did manifest itself as a
significant change in proinflammatory protein expression in these
cells. These observations are supported by a previous report that
DEA-NO can both up- and down-regulate iNOS expression in ANA-1 murine
macrophages (39). Moreover, the production of IL-6 (an
inflammatory cytokine that is regulated via the action of
NF-B(53)) was influenced in a similar manner by NO,
such that following inhibition of endogenous NO synthesis, IL-6
production was significantly retarded following activation with LPS
over the first 9–12 h and then was potentiated to a level above that
seen in control cells at 24–48 h. This provides further evidence that
a diverse range of proteins that are regulated via the activity of
NF-B are modulated in a biphasic manner by NO; whether the
expression of other proinflammatory proteins that are governed by
NF-B (e.g., TNF-) is also subject to the same biphasic regulation
by NO remains to be determined.
The mechanisms invoked by NO to bring about a biphasic regulation of
NF-B activity are currently under investigation; several
possibilities exist (Fig. 8). NO induces
and stabilizes IB (29), which prevents nuclear
localization of NF-B. NO has also be shown to nitrosate a specific
cysteine residue (Cys62) on the p50 subunit of
NF-B to reduce its DNA-binding capacity (30, 31, 32).
Furthermore, reactive oxygen species are believed to be important in
the activation of NF-B (54, 55, 56), and it might be
hypothesized that the rapid interaction of NO with these oxygen
derivatives results in quenching and diminished activation of NF-B.
Each of these process would down-regulate NF-B transcriptional
activity, and one or more may underlie the inhibitory effect on NO
reported in the present study. The activation of NF-B by NO is more
difficult to explain. The most intriguing possibility is via activation
of p21ras. This intracellular signaling protein
has a redox active cysteine residue that is obligatory for Ras
activation in response to oxidative stress (57).
Nitrosation of this cysteine causes the protein to become
constitutively active. Since Ras has been implicated in NF-B
activation (58, 59), in particular in response to
oxidative stress and reactive oxygen species, it is possible that
nitrosation of p21ras is responsible at least in
part for augmentation of NF-B activity by NO. However, the source of
the initial NO that expedites the host defense response is not clear,
but may be from constitutive or inducible NOS. Many immune cells,
including macrophages, are endothelial NOS positive (60, 61), and the small quantities of NO released by this NOS isoform
may be crucial in the early stages of an immune response.
Alternatively, the first iNOS protein expressed may only generate small
local concentrations of NO equivalent to constitutive NOS activity.
|
B activity and immune cell
activation may underlie several observations in the literature that
have remained unexplained. Perhaps most important, the present findings
may explain the ability of NO to exert a dual effect on the activity of
Th1 cells during inflammatory episodes (62, 63). This
effect is mediated at least in part via modulation of the production
and release of IL-12, a cytokine regulated by NF-B
(63, 64, 65, 66). Consequently, the differential effect of NO
could be explained by the biphasic effect of NF-B activity described
in the current study; this would confer on NO a powerful mechanism by
which to regulate the activation profile of Th1 cells. Biphasic
regulation of NF-B by NO may also underlie control of osteoclast
function, which appears to be regulated by a combination of
constitutive and inducible NOS activity in vitro and in vivo (67, 68). Reports suggest that constitutive NOS (i.e., low NO)
augments osteoclast function, and inducible NOS (i.e., high NO) is
inhibitory. Since NF-B has an obligatory role in osteoclast
development and function (69, 70, 71), it seems likely that
this bidirectional effect of NO is the result of the presently reported
activity on NF-B. It should also be noted that NO has a marked
influence on IL-6 activity in an analogous biphasic manner, and since
IL-6 plays a crucial role in bone resorption and osteoclast activity
(72), this provides an additional route via which NO may
govern osteoclast function.
The novel, autocrine pathway characterized in this study involving a
biphasic effect of NO on NF-B activity is easy to reconcile with the
needs of host defense to produce a rapid response to a pathogenic
stimulus that is shut down promptly so as to minimize (host) tissue
damage. Initially, NO-mediated potentiation of NF-B activity will
promote the expression of adhesion molecules and proinflammatory
cytokines to facilitate cellular recruitment to the site of
infection/damage and activate these cells to eradicate the pathogenic
insult. In due course many of these cells will express iNOS, and as a
consequence the concentration of NO in the vicinity will rise and exert
an inhibitory effect on NF-B activity. At this point adhesion
molecule expression would be down-regulated, and proinflammatory
cytokine production arrested to efficiently halt the immunological
process. Undoubtedly, the process of inflammation and host defense
comprises a plethora of signaling and effector molecules, and the
observed effects of NO on NF-B activity are unlikely to be the sole
determinants of the expression of proinflammatory proteins such as
iNOS, COX-2, and IL-6. For instance, posttranscriptional modifications
(i.e., destabilization of iNOS mRNA by TGF- (73)) and
other transcription factors/signaling pathways mobilized following
macrophage activation (i.e., AP-1 (74, 75)) will
undoubtedly influence protein expression; however, since in both humans
(76) and rodents (6, 77) NF-B activation
is imperative for cellular activation and iNOS (and other
proinflammatory protein) expression, the present study indicates that
the biphasic effect of NO on NF-B may represent an essential
framework for regulation of the entire process. Moreover, this
phenomenon may explain why many studies have reported both positive and
negative actions of NO in host defense; the time of intervention with
exogenous NO donors/NOS inhibitors and the local concentration of NO
are critical in determining whether this molecule may augment or
suppress an inflammatory response. This biphasic effect of NO will have
a pronounced effect on cellular recruitment/infiltration, immune cell
function, tissue repair, and antioxidant protection and therefore
promotes NO to the forefront of the regulation of host defense.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. A. J. Hobbs, Wolfson Institute for Biomedical Research, University College London, Cruciform Building, Gower Street, London WC1E 6AE, U.K.
3 Abbreviations used in this paper: iNOS, inducible NO synthase; COX-2, cyclooxygenase-2; DEA-NO, diethylamine-NONOate; L-NAME, NG-nitro-L-arginine methyl ester.
Received for publication September 18, 2000. Accepted for publication January 10, 2001.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705.B in the immune system. Annu. Rev. Immunol. 12:141.[Medline]
B. Proc. Natl. Acad. Sci. USA 93:3308.B. Mol. Pharmacol. 49:15.[Abstract]
B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J. Immunol. 159:3976.[Abstract]
B binding to DNA. Biochem. J. 322:609.
B activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. USA 94:2676.B. J. Biol. Chem. 272:30969.: the role of constitutive NF-B activity. J. Biol. Chem. 271:11317.B in silica and lipopolysaccharide-induced macrophages. Biochem. Biophys. Res. Commun. 214:839.[Medline]
B by nitric oxide mediates inhibition of NF-B. J. Biol. Chem. 270:14214.B DNA binding by nitric oxide. Nucleic Acids Res. 24:2236.B-dependent gene transcription in ANA-1 murine macrophages. J. Immunol. 162:4101.B and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol. Biol. Cell 10:361.-glutamylcysteine synthetase and -glutamyl transpeptidase. FEBS Lett. 448:292.[Medline]
B implies a physiological self-amplifying mechanism. Eur. J. Immunol. 28:2276.[Medline]
plus lipopolysaccharide- induced nitric oxide synthase expression in mouse macrophages. J. Immunol. 155:886.[Abstract]
gene transcription in ANA-1 murine macrophages. Am. J. Physiol. 277:C523.B. Am. J. Physiol. 277:L787.B and AP-1 in lymphocytes. Biochem. Pharmacol. 50:735.[Medline]
B transcription factor and HIV-1. EMBO J. 10:2247.[Medline]
B activation and TNF- gene transcription induced by hypoxia and endotoxin. J. Immunol. 165:1013.B in primary astrocytes. J. Neurochem. 74:2288.[Medline]
B RelA phosphorylation and transcriptional activity by p21ras and protein kinase C
in primary endothelial cells. J. Biol. Chem. 274:13594.B activation in tumor-associated macrophages. J. Immunol. 164:762.B. Eur. J. Immunol. 28:3205.[Medline]
B. Eur. J. Immunol. 27:3461.[Medline]
activates an NF-B-like factor in osteoclast- like cells. J. Biol. Chem. 271:4605.B1 and NF-B2. Nat. Med. 3:1285.[Medline]
. J. Exp. Med. 178:605.B-signaling pathways. Br. J. Pharmacol. 125:193.[Medline]
B-binding sites. J. Biol. Chem. 273:22201.B enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273:15148.B. J. Biol. Chem. 271:6039.This article has been cited by other articles:
|
|
 |
|
  X. M. Wang, H. P. Kim, K. Nakahira, S. W. Ryter, and A. M. K. Choi The Heme Oxygenase-1/Carbon Monoxide Pathway Suppresses TLR4 Signaling by Regulating the Interaction of TLR4 with Caveolin-1 J. Immunol., March 15, 2009; 182(6): 3809 - 3818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Hagos, S. O. Abdul-Hay, J. Sohn, P. D. Edirisinghe, R. E. P. Chandrasena, Z. Wang, Q. Li, and G. R. J. Thatcher Anti-Inflammatory, Antiproliferative, and Cytoprotective Activity of NO Chimera Nitrates of Use in Cancer Chemoprevention Mol. Pharmacol., November 1, 2008; 74(5): 1381 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Marjanovic, A. Stojanovic, V. M. Brovkovych, R. A. Skidgel, and X. Du Signaling-mediated Functional Activation of Inducible Nitric-oxide Synthase and Its Role in Stimulating Platelet Activation J. Biol. Chem., October 24, 2008; 283(43): 28827 - 28834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Li, B. Zhao, C. Wang, H. Wang, Z. Liu, W. Li, H. Jin, C. Tang, and J. Du Regulatory Effects of Hydrogen Sulfide on IL-6, IL-8 and IL-10 Levels in the Plasma and Pulmonary Tissue of Rats with Acute Lung Injury Experimental Biology and Medicine, September 1, 2008; 233(9): 1081 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Marro, C. Peiro, C. M. Panayiotou, R. S. Baliga, S. Meurer, H. H. H. W. Schmidt, and A. J. Hobbs Characterization of the Human {alpha}1{beta}1 Soluble Guanylyl Cyclase Promoter: KEY ROLE FOR NF-{kappa}B(p50) AND CCAAT-BINDING FACTORS IN REGULATING EXPRESSION OF THE NITRIC OXIDE RECEPTOR J. Biol. Chem., July 18, 2008; 283(29): 20027 - 20036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Radke, Z. K. Siddiqui, T. A. Miura, J. M. Routes, and J. L. Cook E1A Oncogene Enhancement of Caspase-2-Mediated Mitochondrial Injury Sensitizes Cells to Macrophage Nitric Oxide-Induced Apoptosis J. Immunol., June 15, 2008; 180(12): 8272 - 8279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vasilijevic, B. Buzadzic, A. Korac, V. Petrovic, A. Jankovic, and B. Korac Beneficial effects of L-arginine nitric oxide-producing pathway in rats treated with alloxan J. Physiol., November 1, 2007; 584(3): 921 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Kelleher, A. Matsumoto, J. S. Stamler, and H. E. Marshall NOS2 Regulation of NF-{kappa}B by S-Nitrosylation of p65 J. Biol. Chem., October 19, 2007; 282(42): 30667 - 30672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Brown, Q. Xu, N. Okhubo, M. P. Vitek, and C. A. Colton Androgen-Mediated Immune Function Is Altered by the Apolipoprotein E Gene Endocrinology, July 1, 2007; 148(7): 3383 - 3390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Mullick, A. F. Powers, R. S. Kota, S. D. Tetali, J. P. Eiserich, and J. C. Rutledge Apolipoprotein E3- and Nitric Oxide-Dependent Modulation of Endothelial Cell Inflammatory Responses Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 339 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Niedbala, B Cai, and F Y Liew Role of nitric oxide in the regulation of T cell functions Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii37 - iii40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. V. Groesdonk, S. Schlottmann, F. Richter, M. Georgieff, and U. Senftleben Escherichia coli Prevents Phagocytosis-Induced Death of Macrophages via Classical NF-{kappa}B Signaling, a Link to T-Cell Activation. Infect. Immun., October 1, 2006; 74(10): 5989 - 6000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shibata, K. Nagata, and Y. Kobayashi A suppressive role of nitric oxide in MIP-2 production by macrophages upon coculturing with apoptotic cells J. Leukoc. Biol., October 1, 2006; 80(4): 744 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Garrean, X.-P. Gao, V. Brovkovych, J. Shimizu, Y.-Y. Zhao, S. M. Vogel, and A. B. Malik Caveolin-1 Regulates NF-{kappa}B Activation and Lung Inflammatory Response to Sepsis Induced by Lipopolysaccharide J. Immunol., October 1, 2006; 177(7): 4853 - 4860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Delgado Alves, L. J. Mason, P. R. J. Ames, P. P. Chen, J. Rauch, J. S. Levine, R. Subang, and D. A. Isenberg Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model Rheumatology, October 1, 2005; 44(10): 1238 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Connelly, M. Madhani, and A. J. Hobbs Resistance to Endotoxic Shock in Endothelial Nitric-oxide Synthase (eNOS) Knock-out Mice: A PRO-INFLAMMATORY ROLE FOR eNOS-DERIVED NO IN VIVO J. Biol. Chem., March 18, 2005; 280(11): 10040 - 10046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Vo, B. Lad, J. A. P. Tomlinson, S. Francis, and A. Ahluwalia Autoregulatory Role of Endothelium-derived Nitric Oxide (NO) on Lipopolysaccharide-induced Vascular Inducible NO Synthase Expression and Function J. Biol. Chem., February 25, 2005; 280(8): 7236 - 7243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Frost, Q. Wang, S. Moncada, and M. Singer Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R394 - R400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Paul-Clark, T. van Cao, N. Moradi-Bidhendi, D. Cooper, and D. W. Gilroy 15-epi-lipoxin A4-mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation J. Exp. Med., July 6, 2004; 200(1): 69 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Hadkar, S. Sangsree, S. M. Vogel, V. Brovkovych, and R. A. Skidgel Carboxypeptidase-mediated enhancement of nitric oxide production in rat lungs and microvascular endothelial cells Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L35 - L45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Okamoto, K. Gohil, E. I. Finkelstein, P. Bove, T. Akaike, and A. van der Vliet Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L198 - L209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Anstead, B. Chandrasekar, Q. Zhang, and P. C. Melby Multinutrient undernutrition dysregulates the resident macrophage proinflammatory cytokine network, nuclear factor-{kappa}B activation, and nitric oxide production J. Leukoc. Biol., December 1, 2003; 74(6): 982 - 991. [Abstract] [Full Text]
|
|
|
|
|
|
S. El-Gayar, H. Thuring-Nahler, J. Pfeilschifter, M. Rollinghoff, and C. Bogdan Translational Control of Inducible Nitric Oxide Synthase by IL-13 and Arginine Availability in Inflammatory Macrophages J. Immunol., November 1, 2003; 171(9): 4561 - 4568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Paul-Clark, F. Roviezzo, R. J. Flower, G. Cirino, P. D. Soldato, I. M. Adcock, and M. Perretti Glucocorticoid Receptor Nitration Leads to Enhanced Anti-Inflammatory Effects of Novel Steroid Ligands J. Immunol., September 15, 2003; 171(6): 3245 - 3252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rodriguez, A. C. Keller, E. L. Faquim-Mauro, M. S. de Macedo, F. Q. Cunha, J. Lefort, B. B. Vargaftig, and M. Russo Bacterial Lipopolysaccharide Signaling Through Toll-Like Receptor 4 Suppresses Asthma-Like Responses Via Nitric Oxide Synthase 2 Activity J. Immunol., July 15, 2003; 171(2): 1001 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Connelly, A. T. Jacobs, M. Palacios-Callender, S. Moncada, and A. J. Hobbs Macrophage Endothelial Nitric-oxide Synthase Autoregulates Cellular Activation and Pro-inflammatory Protein Expression J. Biol. Chem., July 11, 2003; 278(29): 26480 - 26487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sangsree, V. Brovkovych, R. D. Minshall, and R. A. Skidgel Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1959 - H1968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Jacobs and L. J. Ignarro Nuclear Factor-kappa B and Mitogen-activated Protein Kinases Mediate Nitric Oxide-enhanced Transcriptional Expression of Interferon-beta J. Biol. Chem., February 28, 2003; 278(10): 8018 - 8027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Niedbala, X.-q. Wei, C. Campbell, D. Thomson, M. Komai-Koma, and F. Y. Liew Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP PNAS, December 10, 2002; 99(25): 16186 - 16191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fiorucci, E. Antonelli, E. Distrutti, P. Del Soldato, R. J. Flower, M. J. P. Clark, A. Morelli, M. Perretti, and L. J. Ignarro NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice PNAS, November 26, 2002; 99(24): 15770 - 15775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Franek, Y. C. Chowdary, X. Lin, M. Hu, E. J. Miller, J. A. Kazzaz, P. Razzano, J. Romashko III, J. M. Davis, P. Narula, et al. Suppression of Nuclear Factor-kappa B Activity by Nitric Oxide and Hyperoxia in Oxygen-resistant Cells J. Biol. Chem., November 1, 2002; 277(45): 42694 - 42700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K Reddy, S. K.G Koshy, and H. Shukia Triggers and promoters of ischaemic preconditioning Cardiovasc Res, October 1, 2002; 56(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
Y.-P. Wang, C. Sato, K. Mizoguchi, Y. Yamashita, M. Oe, and H. Maeta Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase Cardiovasc Res, October 1, 2002; 56(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zoll, W. J. G. Melchers, J. M. D. Galama, and F. J. M. van Kuppeveld The Mengovirus Leader Protein Suppresses Alpha/Beta Interferon Production by Inhibition of the Iron/Ferritin-Mediated Activation of NF-{kappa}B J. Virol., August 28, 2002; 76(19): 9664 - 9672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Skidgel, X.-p. Gao, V. Brovkovych, A. Rahman, D. Jho, S. Predescu, T. J. Standiford, and A. B. Malik Nitric Oxide Stimulates Macrophage Inflammatory Protein-2 Expression in Sepsis J. Immunol., August 15, 2002; 169(4): 2093 - 2101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rachlis, J. L. Watson, J. Lu, and D. M. McKay Nitric oxide reduces bacterial superantigen-immune cell activation and consequent epithelial abnormalities J. Leukoc. Biol., August 1, 2002; 72(2): 339 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Benjamim, J. S. Silva, Z. B. Fortes, M. A. Oliveira, S. H. Ferreira, and F. Q. Cunha Inhibition of Leukocyte Rolling by Nitric Oxide during Sepsis Leads to Reduced Migration of Active Microbicidal Neutrophils Infect. Immun., July 1, 2002; 70(7): 3602 - 3610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. F. Nascimento, V. L. G. Calich, D. Rodriguez, and M. Russo Dual Role for Nitric Oxide in Paracoccidioidomycosis: Essential for Resistance, but Overproduction Associated with Susceptibility J. Immunol., May 1, 2002; 168(9): 4593 - 4600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. ZINGARELLI, P. W. HAKE, Z. YANG, M. O'CONNOR, A. DENENBERG, and H. R. WONG Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-{kappa}B and AP-1 activation and enhances myocardial damage FASEB J, March 1, 2002; 16(3): 327 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Reuter, H. Bolay, I. Jansen-Olesen, A. Chiarugi, M. S. del Rio, R. Letourneau, T. C. Theoharides, C. Waeber, and M. A. Moskowitz Delayed inflammation in rat meninges: implications for migraine pathophysiology Brain, December 1, 2001; 124(12): 2490 - 2502. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
) or L-arginine
(L-Arg)-free medium (•). Protein expression was analyzed
by Western blot (A), and bands were quantified by
densitometry (B). Data are represented as the mean
± SEM density, expressed as a percentage of peak protein under each
condition (n > 3).
